Crude Oil (CL)

에 대한 최신 뉴스 Colgate-Palmolive (NYSE:CL) 주식

COLGATE-PALMOLIVE CO

Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Cincinnati,-,Circa,February,2019:,Procter,&amp;,Gamble,Corporate,Headquarters

News

프록터 앤드 갬블, 새로운 구조조정 전략으로 7,000개 직무 감축 및 브랜드 매각

michael burry

Asia

Equities

Large Cap

Sector ETFs

Specialty ETFs

Hedge Funds

Commodities

Tech

ETFs

AMZN

BABA

BIDU

FSLR

GOOGL

NXST

ORCL

PHYS

TSLA

2008년 경제 위기를 예언한 전설적인 투자가 마이클 버리가 자신의 헤지 펀드 사이언 에셋 매니지먼트(Scion Asset Management LLC)의 최신 13F 보고서를 제출하며 다시 한 번 주목받고 있다.

&#39;빅 쇼트&#39; 투자자 마이클 버리, 금과 재생에너지 주식에 큰 베팅···아마존과 알파벳에서는 철수

Milan,,Italy,-,August,10,,2017:,Colgate-palmolive,Logo,On,The

Earnings

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

콜게이트 팜올리브 컴퍼니(NYSE:CL)는 4월 25일 금요일 개장 전에 1분기 실적을 발표할 예정이다. 애널리스트들은 콜게이트 팜올리브의 주당순이익은 86센트로 예상하고 있으며, 이는 전년 동기와 동일하다. 또한 분기 매출은 48억 6천만 달러로 전년 동기의 50억 7천만 달러보다 감소할 것으로 예상한다.

콜게이트 팜올리브 1분기 실적 발표 임박, 월가 가장 정확한 애널리스트 의견 변동은?

Colgate-Palmolive Co

Core One Labs Inc

CHINA LIAONING DINGXU ECO by China Liaoning Dingxu Ecological Agriculture Development, Inc.

China Liaoning Dingxu Ecological Agriculture Development Inc

Clarus Corp

CHAVANT CAPITAL ACQUISITION CORP UNIT 1 COM & 1/3 WT EXP

CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC.

Claritas Pharmaceuticals Inc

Core Laboratories Inc

CALBEE Inc

Columbia Financial Inc

CALIBER ENERGY INC by Caliber Energy, Inc.

Colombier Acquisition Corp. II Class A Ordinary Shares

Colombier Acquisition Corp II

Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant

Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share

Cellebrite DI Ltd

CHRISTINA LAKE CANNABIS by Christina Lake Cannabis Corp.

Christina Lake Cannabis Corp

CLICKS GROUP LTD S/ADR by Clicks Group Ltd

Clicks Group Ltd

CENTRAL CHINA SECS S/ADR by Central China Securities Co. Ltd.

Calcol Inc

Sinch AB

Cool Co Ltd

CEL CORP by CEL CORP.

Cell Source Inc

CapitaLand China Trust

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics Inc

Direxion Daily Cloud Computing Bull 2X Shares

Chatham Lodging Trust (REIT) Common Shares of Beneficial Interest

Chatham Lodging Trust

Chatham Lodging Trust (REIT) 6.625% Series A Cumulative Redeemable Preferred Shares of Beneficial Interest

Cloud3 Ventures Inc Ordinary Shares (Sub Voting)

CLOUD3 VENTURES INC by Cloud3 Ventures Inc.

Cloud3 Ventures Inc

Calidi Biotherapeutics Inc Warrants (01/01/9999)

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics Inc

Coles Group Ltd

COLES GROUP LTD UNSP/ADR by Coles Group Ltd.

China Liberal Education Holdings Ltd Ordinary Shares

CHINA LIBERAL ED HLDG INC by China Liberal Education Holdings Limited

China Liberal Education Holdings Ltd

CONCRETE LEVELING SYS INC by Concrete Leveling Systems Inc.

Concrete Leveling Systems Inc

Cleveland-Cliffs Inc

Clearfield Inc

CLIFFORD MDERN IVING HLD by CLIFFORD MODERN LIVING HLDGS LTD.

CLARITY METALS CORP by Clarity Metals Corp.

Clarity Metals Corp

Aris Mining Corp

CLEGHORN MINERALS ORD by Cleghorn Minerals

Cleghorn Minerals Ltd

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

CLEANGO INNOVATIONS INC by CleanGo Innovations Inc.

CleanGo Innovations Inc

CLEAN SEED CAP GROUP LTD by Clean Seed Capital Group Ltd

Clean Seed Capital Group Ltd

Cloud Nine Web3 Technologies Inc

HUTECH21 CO LTD NEW by Hutech21 Co., Ltd.

Clean Harbors Inc

ClearDAO

CLST Holdings Inc

COLTENE HOLDING AG ORD by Coltene Holding AG

Coltene Holding AG

Tidal Trust II Veridien Climate Action ETF

Energy Plug Technologies Corp

CORDLIFE GROUP LTD ORD by Cordlife Group Ltd

Cordlife Group Ltd

CLS HOLDINGS PLC ORD by CLS Holdings Plc.

CLS Holdings PLC

Click Holdings Ltd

CAPITALAND INVESTMENT LTD by Capitaland Investment Ltd.

CapitaLand Investment Ltd

CLEAN EARTH ACQUISITIONS CORP RT

CLEAN EARTH ACQUISITIONS CORP UNIT 1 CL A COM & 1 RT 1/2 RED WT EXP

CLEAN EARTH ACQUISITIONS CORP RED WT EXP

Global X Funds Global X 1-3 Month T-Bill ETF

ClearSign Technologies Corporation - Common Stock

ClearSign Technologies Corp

CLEARFORD WATER SYS INC by Clearford Water Systems, Inc.

Clearford Water Systems Inc

ClickStream Corp

CITY OF LONDON INVST GRP by City of London Investment Group PLC

City of London Investment Group PLC

ProShares Long Online/Short Stores ETF

Clarke Inc

Calcitech Ltd

TWC ENTERPRISES LTD ORD by TWC Enterprises Ltd.

TWC Enterprises Ltd

CLAYTON & LAMBERT MFG CO by Clayton & Lambert Manufacturing Co.

CHALLENGER GOLD LIMITED by Challenger Gold Limited

Challenger Gold Ltd

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

BICO Group AB

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

CELLNEX TELECOM UNSP/ADR by Cellnex Telecom SA

Cellnex Telecom SA

Cellectis S.A. - American Depositary Shares

Cellectis SA

CALLINEX MINES INC by Callinex Mines Inc.

Callinex Mines Inc

Cornerstone Strategic Investment Fund, Inc. Common Shares

Cornerstone Strategic Value Fund Inc

Climb Global Solutions, Inc. - Common Stock

Climb Global Solutions Inc

CALIMA ENERGY LTD NEW by Calima Energy Ltd.

Calima Energy Ltd

CALGRO M3 HOLDINGS LTD by Calgro M3 Holdings Ltd.

Calgro M3 Holdings Ltd

Climeon AB ass B

Climeon AB

CANADIAN PREM SAND by Canadian Prem Sand Inc.

Canadian Premium Sand Inc

Calumet Inc

Clean Energy Fuels Corp

CALIAN GROUP LTD ORD by Calian Group Ltd.

Calian Group Ltd

Clene Inc

IndexIQ ETF Trust NYLI Cleaner Transport ETF

CLEAN VISION CORPORATION by Clean Vision Corporation

Clean Vision Corp

CELLNEX TELECOM SA ORD by Cellnex Telecom SA

Callisto - United States Dollar

iShares AAA CLO Active ETF

Looking into the current session, Colgate-Palmolive Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares are trading at $91.90, after a 1.13% increase. Moreover, over the past month, the stock spiked by 4.57%, but in the past year, fell by 1.43%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749571223_0_0.png" alt="Past Year Chart" />

<h3>How Does Colgate-Palmolive P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 24.72 in the Household Products industry, Colgate-Palmolive Inc. has a higher P/E ratio of 25.74. Shareholders might be inclined to think that Colgate-Palmolive Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749571223_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Colgate-Palmolive

No one likes a flip-flopper, whether in politics or stocks. When a stock can't make up its mind on a direction or trend, it can drive investors to abandon their positions in search of greener pastures.&nbsp;
This can create headaches in other areas, such as tax bills, trading fees, and overtrading, which can all be very costly. If you believe in a company&#8217;s long-term prospects but think in the short term that the stock will keep going sideways, there&#8217;s a better strategy than selling.
There&#8217;s a trading strategy that can let you collect income while you wait for the stock to grow to its full potential.
The strategy in question &#8211; covered calls &#8211; is used to earn income from a range-bound asset by selling a call option on a stock you already own. In this trade, you would sell a call option with a strike price slightly above the stock's current market price and collect the upfront premium. Your obligation to the option buyer is "covered" by the 100 shares you already own. If the strike price is reached and the call is exercised, you deliver 100 shares to the buyer and retain the premium.
However, if the call expires without hitting the strike, you keep the stock and pocket the premium as a profit. The upside is limited, but your downside risk is protected by collecting the premium and owning the stock.
A covered call is a neutral strategy, so your max profit is limited to the option premium. If the stock price increases too much, the option buyer will exercise the contract and claim the shares you hold at the strike price. And if the stock declines, the income from the option premium offsets some of your losses.
Today, we'll examine five stocks exhibiting range-bound behavior that could be suitable candidates for covered calls over the next few months. If you own any of the companies listed below, consider whether a covered call strategy aligns with your investment goals and risk tolerance.
<h2 class="wp-block-heading">JM Smucker Co. </h2>
JM Smucker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) makes popular snack treats and coffee, such as Uncrustables, Folgers, Carnation, and JIF, along with pet food brands like Meow Mix and Milk-Bone. The company has had uneven revenue over the last few years, and profit margins have sagged from the consistent 7-9% figures produced from 2021 to 2023.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdOLILELt0easPJVO3FPlgkXTVdp87VMIYzaJFJF9u-qW7TwyKSBxEC56eE0xgruqTv_xEpxJz2ZHrYcHR9jdqwlsv4F7qRPe8Rfdf4gOKePiGVISfwQxXNLkoDVQq_wXgr9qrg7g?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
The stock has struggled as well, trading in a downtrending range for the better part of the last 18 months. While revenue growth has been spotty, the company appeals to income investment thanks to a 3.8% yield and 27 years of consecutive payout increases. On the daily chart, the RSI shows that the range-bound trading is likely to continue, making SJM a strong covered call candidate. The call option strike price should be set above the upper trendline on the chart, and investors can collect both dividend income and option premium. 
<h2 class="wp-block-heading">The Fed's About To Move The Market—Here's How Chris Capre Is Trading It</h2>
On June 11 at 6 PM ET, Chris Capre is going live to break down how he's preparing for the next Fed decision—before it hits and after the market reacts. You'll get his full options strategy, including pre-FOMC setups, post-reaction frameworks, and the tickers he's targeting for fast-moving trades. Secure your spot for free right <a href="https://events2.benzinga.com/chris-capre-webinar-wed-june11-2025/?utm_campaign=webinar061125&amp;utm_adType=RD051025&amp;utm_ad=061125">HERE</a>.
<h2 class="wp-block-heading">Ford Motor Co. </h2>
It's been a rough few years for Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>). The stock made new all-time highs during the 2021 bull market but lagged behind during the recovery from the 2022 bear market. The stock has been range-bound since mid-2022, trading between $9 and $15 for the better part of three years.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXePqqBCpRXN0Y7hol45T9gqw7XXm8KACWYRLlW0CH-cS_hn7tqu8nrNhXAr4vK7tfqVD4OrjgFJTTTgVvcL6znjpHTdQMJ3zHPbpKPTgcHzUMLQiMyxMsLnhG0ES4cUu3vif0AO8A?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
Ford shares could continue trading in this range even longer as the company's electrification goals will take years. Tariffs could also hit the Big Three automakers hard, although Ford has more domestic production than competitors like GM. With a Price-to-Earnings ratio under nine and a dividend yield over 7%, the stock is attractive to value investors, but it&#8217;s hard to get overly bullish on a stock facing so many potential headwinds. Ford is currently trading near the lower bound of its range, which means less premium collected on the call option, but also a slimmer chance of the stock reaching the strike price (which should be set around the $15 resistance level). 
<h2 class="wp-block-heading">Colgate-Palmolive Co. </h2>
Consumer staples companies like Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) make decent covered call candidates since they often have thin margins, steady demand, and low beta stocks. In other words, they don&#8217;t move much. However, CL shares make a different type of candidate as the stock's range has been narrowing in a wedge pattern, which could signal a consolidation of capital preparing to alter the current trend.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcieA8vY92exaX52Nb2uad0_5EgocO70FInhRxzV0KJ0rw9xtSkfiqxuuADK5dtgMn18SaXGbhjc6zW4bJe8NBOx1DVS9OEinfNl2Zo1713WoAYJC0jAbUE0orMznT72lx3lKJz1w?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
However, CL's wedge still has a wide range, and the stock is currently bumping up against the upper bound. Here's why CL is a good covered call candidate: if the stock fails to break above the trendline, it indicates the trend breakout isn't imminent, and the premium collected from selling a call at this level will be hefty. If the stock does break through the trendline, the trade idea can (and should) be aborted.
<h2 class="wp-block-heading">Walt Disney Co. </h2>
Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) has seen its own share of highs and lows over the last few years. Like Ford, the company has failed to recapture its all-time highs from 2021 and lagged the S&amp;P 500 as stocks recovered in 2023 and 2024. However, the company is seeing a revival of its theme park businesses and profit margins have expanded for four consecutive quarters. 
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXfpLcfj-v5EFnOWJvyaEEQ5aNKnyEvirt8IlccF_nQdoDnAJ9EdSFYGKSa9g0VEe5tb8g-rqeXFF6WHvq19OUl2dnovK8t3RpyxGsHcWxH5HahnqQ6zgr2sK0qjMVVa3YKS-yU7?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
So why is Disney stuck in this long-term range? Despite revenue expansion, Disney+ subscriber growth is actually starting to decline, and the company continues to struggle to find direction for sports properties like ESPN. The stock hasn't traded above $123 per share since August 2022, and the current market price is right at the resistance level of the range. Despite gains of more than 20% this month, Disney could be tapped out, making it ideal for a covered call if you own it.
<h2 class="wp-block-heading">Allstate Corp. </h2>
Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) reached a new all-time high as recently as March, and placing a resistance trendline at an all-time high can be risky when trading. But this is the third time ALL shares have approached this level; the first two attempts failed to continue the momentum. The more attempts a stock makes to break a resistance level, the stronger that level becomes. A third failure could be bad news for shareholders.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcNOFR_urReKPRZbHDQTKSWlvvgPZF1ZItZ-wkaUsGvmm75gQ1zG5uaN-JyINkWUhiNwUHmiQieGeA474tsCbqu7k2TU-xexByziafPa-uECQablzgqQrLl17S1QHrlfIHc6hZcdw?key=Vna2qS5bZFcM3OU-gqusIA" alt="" /></figure>
A covered call can protect your investment should the stock fail to breach the $213 level again. If the stock does make a new all-time high, don't write the call; enjoy the profits you earn from owning it. But if it looks like the stock has once again failed to break through and trends lower, the premium collected from selling the call can help offset the retreat back to support.
Editorial content from our expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Personal Finance

5 Best Stocks To Trade For Income

Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) unveiled a sweeping overhaul on Thursday at the 2025 Deutsche Bank Global Consumer <a target="_blank" href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0000080424/995e4954-0a90-46da-8215-51b98f42f344.html" rel="noreferrer noopener">Conference</a>. It outlined a strategy to simplify operations and sharpen its focus on core growth areas.
The move is part of a broader effort to boost efficiency and enhance long-term value for shareholders.
The restructuring plan includes cost-cutting initiatives and the elimination of up to 7,000 roles, primarily targeting non-manufacturing functions.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45789179/top-3-consumer-stocks-youll-regret-missing-this-quarter." rel="noreferrer noopener">Top 3 Consumer Stocks You&#8217;ll Regret Missing This Quarter</a>
P&amp;G anticipates taking pre-tax charges ranging between $1 billion and $1.6 billion over the next two fiscal years, with about 25% of those being non-cash charges tied to asset write-downs.
Procter &amp; Gamble intends to streamline its portfolio by divesting underperforming brands and exiting select markets. It also plans to revamp its supply chain using automation and digital tools while reducing organizational layers to cut overhead and reinvest in brand development.
For <a target="_blank" href="https://www.benzinga.com/25/04/44984872/gillette-parent-procter-gamble-slides-on-q3-sales-decline-lowered-outlook" rel="noreferrer noopener">the third quarter</a>, the company&#8217;s organic revenue climbed 5%, driven mainly by pricing strategies. Net income grew 8% to $8.6 billion, while GAAP earnings per share reached $3.49. Core EPS rose 4% to $3.81, and free cash flow productivity remained above 100%.
P&amp;G expects flat all-in sales and 2% organic growth for fiscal 2025. It lowered adjusted EPS guidance and forecasted $200 million in headwinds from commodities and forex. Dividend and buyback plans remain unchanged.
Related: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45020318/what-is-the-tariff-risk-for-procter-gamble-analyst-calculates-trims-outlook" rel="noreferrer noopener">What Is The Tariff Risk For Procter &amp; Gamble? Analyst Calculates, Trims Outlook</a>
P&amp;G also flagged external risks, including inflation, currency volatility, and global geopolitical issues. Yet the company expressed confidence in its long-term growth outlook, pointing to rising e-commerce demand, ongoing innovation in premium offerings, and increased exposure to developing markets.
Related ETFs: Consumer Staples Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>), Vanguard Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>).
Price Action: PG shares are trading lower by 0.15% to $165.70 premarket at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/asia/25/06/45791216/citi-to-cut-3500-tech-jobs-in-china-in-global-restructuring-spree" target="_blank" rel="noreferrer noopener">Citi To Cut 3,500 Tech Jobs In China In Global Restructuring Spree</a></li>
</ul>
Photo via Shutterstock

Procter & Gamble To Eliminate 7,000 Roles, Divest Brands In New Restructuring Strategy

Jim Cramer thinks that the bond market now offers a clearer risk-reward trade-off than so-called "safety" stocks, warning that rising 10-year Treasury yields and a political "wild card" in Washington make even dividend stalwarts feel shaky.
What Happened: The 10-year Treasury yield's jump to its highest level in more than a month has tightened the spread between bond payouts and blue-chip dividends, dulling the appeal of AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), Cramer <a href="https://www.cnbc.com/2025/05/14/jim-cramer-explains-why-its-hard-to-own-usual-safety-stocks-here.html">told</a> CNBC&#8217;s &#8216;Mad Money&#8217; viewers on Wednesday.
"In a very uncertain tape for what <a href="https://www.benzinga.com/content/44809259/3-safe-dividend-stocks-as-investors-seek-to-reset-diversification">used to be called</a> ‘safety stocks,' I'd rather just own a piece of paper like the 10-year Treasury, where, if worst comes to worst, at least I get my money back," Cramer said.
Cramer flagged Robert F. Kennedy Jr., newly installed as Health and Human Services secretary, as an <a href="https://www.benzinga.com/markets/equities/24/11/42254495/trumps-hhs-pick-rfk-jr-has-a-long-history-of-challenging-global-health-policies">unpredictable force</a> who could clamp down on pharmaceutical pricing and food additives. "Investors don't know whether Kennedy will act in favor of the companies he's tasked with regulating," he cautioned.
See also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45426516/chuck-schumer-says-trump-is-letting-cartel-members-into-the-us-asks-how-much-memecoin-did-they-pay">Chuck Schumer Says Trump Is &#8216;Letting Cartel Members&#8217; Into The US, Asks How Much &#8216;Memecoin&#8217; Did They Pay</a>
What To Know: That uncertainty compounds existing headaches. Johnson &amp; Johnson is <a href="https://www.benzinga.com/general/biotech/25/04/44586129/us-judge-rejects-another-johnson-johnson-attempt-to-use-bankruptcy-for-talc-cancer-claims">still wrestling</a> with talc-related lawsuits that have already cost billions in settlements and reserves, a cloud Wall Street <a href="https://www.benzinga.com/25/04/44920880/expert-flags-never-before-observed-trio-falling-stocks-and-short-yields-bucking-rising-long-yields-nothing-is-normal-about-this">fears could grow</a> heavier if bond yields <a href="https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness?utm_source=chatgpt.com">keep luring</a> income-seekers away. AbbVie's rich dividend likewise looks less generous when a risk-free Treasury pays nearly the same rate with zero headline risk.
Consumer staples aren't immune either, says Cramer. Procter &amp; Gamble and Colgate boast recession-proof brands, yet their 2–3% yields no longer tower over Treasuries, and Cramer said "the yields may simply not be high enough to justify the risk."
Snack titan PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) and cereal maker General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) could also <a href="https://www.benzinga.com/government/regulations/24/11/42144709/kennedys-war-on-food-dyes-could-be-coming-to-your-breakfast-table">come under fire</a> if Kennedy pushes to restrict artificial colors and other additives, Cramer warned, asking rhetorically whether kids would still eat Lucky Charms without its rainbow marshmallows.
Why It Matters: For now, Cramer said he is "tempted to buy General Mills" on weakness, but fears Washington's next pitch more than the stock's upside.
Cramer also told "Mad Money" viewers that recession worries can be a buying opportunity, saying high-quality retailers look cheap so long as you don't think the economy will "fall off a cliff." Despite earlier warning, the sector was in the trade-war "blast radius," he now does have a <a href="https://www.benzinga.com/25/05/45416455/jim-cramer-says-these-retail-stocks-rl-gap-can-survive-a-market-correction">couple of clear favorites</a> to scoop up on any dip.
Benzinga Edge Stock Rankings indicate Johnson &amp; Johnson has a Momentum in the 47th percentile and Growth in the 63rd, how do other &#8220;safety&#8221; stocks rank in terms of these metrics? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Check them out here</a>.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="442" height="282" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33.png" alt="" class="wp-image-915950" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33.png 442w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33-300x191.png 300w" sizes="(max-width: 442px) 100vw, 442px" /></figure>
Photo courtesy: katz / Shutterstock.com
Read next: <a href="https://www.benzinga.com/general/travel/25/05/45427289/peter-schiff-warns-qatars-200-billion-boeing-deal-could-spike-us-inflation-interest-rates-says-treasury-sell-off-may-follow">Peter Schiff Warns Qatar&#8217;s $200 Billion Boeing Deal Could Spike US Inflation, Interest Rates — Says Treasury Sell-Off May Follow</a>

ABBV

Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets

Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) posted better-than-expected first-quarter FY25 <a href="https://www.benzinga.com/quote/CL/earnings">earnings on Friday</a>.
The company&#8217;s first-quarter FY25 sales declined 3% year over year to $4.91 billion, beating the analyst consensus estimate of $4.86 billion. Non-GAAP EPS of $0.91 beat the consensus estimate of $0.86.
&#8220;As we look ahead, uncertainty and volatility in global markets, including the impact of tariffs, remain challenging. We are confident in our strategy and will continue to execute with focus and agility to mitigate these factors and achieve our revised 2025 financial targets,&#8221; said Chairman, President, and CEO Noel Wallace.
For FY25, Colgate said it expects net sales to be up in the low single digits, including a negative impact from foreign exchange in the low single digits. The company anticipates organic sales growth to be 2% to 4%.
Colgate shares fell 3% to trade at $91.08 on Monday.
These analysts made changes to their price targets on Colgate following earnings announcement.
<ul>
<li>JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 to $103.</li>
<li>Citigroup analyst Filippo Falorni maintained Colgate-Palmolive with a Buy and raised the price target from $103 to $108.</li>
</ul>
Considering buying CL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-1024x560.png" alt="" class="wp-image-891420" style="width:532px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200.png 1172w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>

Colgate-Palmolive Analysts Increase Their Forecasts After Upbeat Results

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and raises the price target from $103 to $108.

Citigroup Maintains Buy on Colgate-Palmolive, Raises Price Target to $108

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight and raises the price target from $95 to $103.

JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $103

After months of sluggish performance, cannabis stocks finally caught a break. Federal reform chatter—this time involving Donald Trump—helped fuel a rally across the sector. But even with this uptick, analysts are urging caution.
Beyond the markets, the global cannabis map keeps evolving: Portugal has quietly become Europe's biggest exporter, Spain banned HHC and Argentina passed a sweeping "anti-mafia" law raising concerns for patients and cannabis activists. Meanwhile, California cities slash taxes to save local stores and a cult rolling paper brand opened its factory doors to the public for the first time ever.
Let's dive in.
<h2 class="wp-block-heading">Politics And Policy</h2>
<h3 class="wp-block-heading">Trump Reportedly Pushing For SAFE Banking Reform</h3>
The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) closed the week up 9.7% after reports that Trump is privately encouraging lawmakers to pass banking reform ahead of the 2026 midterms. Analysts say the rally is likely technical unless public support follows.
Read more on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp">Benzinga</a>
<h3 class="wp-block-heading">Argentina's New Anti-Mafia Law Raises Civil Rights Concerns</h3>
Passed last month, Argentina&#8217;s new law allows authorities to detain suspects, seize property and wiretap phones without judicial approval in designated zones. Experts fear the law could be used to target medical cannabis users and community organizations.
Read more on <a class="" href="https://elplanteo.com/ley-antimafia-argentina/">El Planteo</a>
<h3 class="wp-block-heading">Hungary Ramps Up Drug War Ahead of Elections</h3>
Hungary is pushing a constitutional amendment to criminalize drug use and give law enforcement broader powers. Critics say the government is using prohibitionist rhetoric to boost voter support.
Read more on <a class="" href="https://elplanteo.com/hungria-guerra-drogas/">El Planteo</a>
<h3 class="wp-block-heading">Spain Bans HHC And Other Semi-Synthetic Cannabinoids</h3>
Spain added HHC and several related compounds to its list of controlled substances, effectively banning their sale and distribution nationwide.
Read more on <a class="" href="https://elplanteo.com/espana-prohibe-hhc-cannabinoides/">El Planteo</a>
<h3 class="wp-block-heading">Portugal Nearly Triples Cannabis Exports</h3>
Portugal exported 32,558 kilos of cannabis in 2024, a 172% increase over the prior year. It now ranks as the largest cannabis exporter in Europe and second globally behind Canada.
Read more on <a class="" href="https://www.theportugalnews.com/news/2025-04-24/portugal-cannabis-exports-almost-triple/97136">The Portugal News</a>
<h2 class="wp-block-heading">Markets And Stocks</h2>
<h3 class="wp-block-heading">Body And Mind Sells Long Beach Dispensary For $856K</h3>
Body and Mind Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/BAMM#CSE">BAMM</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) is divesting its Long Beach location for $856,250. The company is shifting its focus to retail expansion in Illinois and New Jersey.
<h3 class="wp-block-heading">Green Market Report Closes Its Doors</h3>
Green Market Report, one of the few cannabis-focused financial news outlets, has shut down. Founder Debra Borchardt confirmed that Crain Communications, which acquired the site in 2022, decided to discontinue operations. All staff members have been laid off except veteran journalist John Schroyer, who will remain at Crain to cover cannabis and other sectors.
The closure is a major loss for the industry—and a stark reminder of how vulnerable cannabis media remains. With few specialized outlets left standing, supporting independent reporters and sector-specific journalism is more essential than ever. Generalist coverage often misses the nuance, science and community insight that cannabis reporting requires.
If you wonder how you can support your favorite media outlets and journalists, <a href="mailto:javierhasse@benzinga.com">email me</a>.
<h2 class="wp-block-heading">Culture And Commentary</h2>
<h3 class="wp-block-heading">Inside The RAW Factory: Where Iconic Papers Are Born</h3>
In a rare behind-the-scenes look, Benzinga visited RAW's Spanish production site in Benimarfull. Founder Josh Kesselman walked us through the machines, secrecy and craftsmanship behind the world's most famous rolling paper brand.
Read more on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44992856/willy-wonka-of-weed-opens-the-doors-to-the-raw-factory-heres-what-we-saw">Benzinga</a>
Watch the <a href="https://www.youtube.com/watch?v=6TRFUO4_Yng">video</a> below:
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The WILLY WONKA OF WEED Opened The Doors To The RAW Factory: Here's What We Saw" width="500" height="281" src="https://www.youtube.com/embed/6TRFUO4_Yng?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h2 class="wp-block-heading">Business And Brands</h2>
<h3 class="wp-block-heading">Curaleaf Debuts Anthem Pre-Roll Brand</h3>
Curaleaf Holdings, Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) launched a new pre-roll brand, Anthem, now available in New York, New Jersey, Illinois, and Massachusetts. Additional state launches are planned for summer.
<h3 class="wp-block-heading">Wynk Expands Into Four More States</h3>
Hemp seltzer brand Wynk is now available in Kentucky, Arkansas, Alabama and Wisconsin—building on its presence in New Jersey, Texas and Florida. The company has secured major retail placements and distributor partnerships in each new state.
<h3 class="wp-block-heading">Humboldt Seed Co. Releases OG Triploid Autoflower Strain</h3>
Humboldt Seed Company launched an OG triploid autoflower strain boasting 30–34% THC and fast flowering times. It's non-GMO and bred for outdoor cultivators looking to match indoor potency and yield.
<h2 class="wp-block-heading">Industry And Infrastructure</h2>
<h3 class="wp-block-heading">Cresco Labs Opens $15M Cultivation Facility In Kentucky</h3>
Cresco Labs (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#CSE">CL</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) cut the ribbon on a $15.4 million facility in Winchester, KY. The site is expected to be operational by year-end and will support the state's newly launched medical cannabis program.
<h3 class="wp-block-heading">California Cities Slash Taxes As Stores Struggle</h3>
Cities across the Coachella Valley—including Desert Hot Springs and Palm Springs—are reducing cannabis taxes in response to widespread retail closures. Sonoma County followed suit, while San Diego and the state move in the opposite direction.
Read more on <a class="" href="https://www.sfgate.com/cannabis/article/california-cannabs-tax-rates-fall-20281817.php">SFGate</a>
<h2 class="wp-block-heading">Recommended Reads</h2>
<a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/24/carmelo-anthonys-cannabis-mission-comes-home-i-know-the-door-i-hold-open/">Carmelo Anthony's Cannabis Mission Comes Home: ‘I Know The Door I Hold Open'</a> NBA legend Carmelo Anthony opens up about cannabis advocacy, business ownership and legacy-building in New York.
<a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/22/is-america-missing-out-on-the-global-cannabis-boom/">Is America Missing Out On The Global Cannabis Boom?</a> As Europe, Latin America, Asia and Africa expand cannabis markets, U.S. inaction threatens its leadership position globally.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/45018519/how-local-opposition-threatens-long-islands-cannabis-market-and-what-that-means-for-investors">How Local Opposition Threatens Long Island&#8217;s Cannabis Market And What That Means For Investors</a> Local bans and delays are creating major hurdles for New York's cannabis rollout—especially in suburban strongholds.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44957196/these-are-the-cannabis-industrys-power-players-according-to-forbes">These Are The Cannabis Industry&#8217;s Power Players, According To Forbes</a> Forbes unveils its latest list of top cannabis executives, entrepreneurs and advocates shaping the industry's future.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44956994/145-years-later-zig-zag-gets-loud-about-weed-with-times-square-takeover">145 Years Later, Zig-Zag Gets Loud About Weed With Times Square Takeover</a> The iconic rolling paper brand embraces cannabis culture with a bold advertising splash in the heart of New York.
<a class="" href="https://www.benzinga.com/25/04/44934689/snoop-doggs-last-dance-is-cannabis-cinema-at-its-weirdestand-its-got-funkadelic-dad-rock-counterpart">Snoop Dogg&#8217;s &#8216;Last Dance&#8217; Is Cannabis Cinema At Its Weirdest—And There&#8217;s A Funkadelic &#8216;Dad Rock&#8217; Counterpart</a> Snoop Dogg releases a psychedelic music video tribute to cannabis culture.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44929611/why-pre-rolls-are-cannabis-most-profitable-format-from-california-to-canada">Why Pre-Rolls Are Cannabis&#8217; Most Profitable Format, From California To Canada</a> Pre-rolls are dominating retail shelves and margins, solidifying their status as the cannabis industry&#8217;s breakout category.
That's it for this week. See you next Friday with another roundup of what's shaping the cannabis world—on Wall Street, in Washington and around the globe.

Cannabis

Politics

BMMJ

CRLBF

CSE:BAMM

CSE:CL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

MSOS

TSX:CURA

This Week In Cannabis: Trump's Reform Buzz Drives Stocks Up, RAW's Secret Factory, Global Shifts And More

Wall Street's three-day rally came to a pause on Friday, with major indices hovering near the flatline by midday in New York as caution returned amid mixed signals on <a href="https://www.benzinga.com/news/global/25/04/45004954/china-reportedly-begins-exempting-key-us-imports-from-tariffs-including-pharma-and-aerospace-parts">U.S.-China trade relations.</a>
President Donald Trump claimed to have held a phone call with President Xi Jinping, yet Chinese officials denied that any talks had taken place.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) extended its rally into a fourth consecutive session, notching its best weekly performance of the year with a 16% gain. On Thursday afternoon, Transportation Secretary Sean Duffy introduced a new regulatory framework for self-driving vehicles, saying it aimed to reduce bureaucratic hurdles and advance toward a unified national standard.
T-Mobile US Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NYSE">TMUS</a>) was the biggest laggard of the day, falling 11%, on track for its worst single-day loss since March 2020. This came despite better-than-expected earnings, as its core wireless business posted slower growth than analysts had projected.
Among sectors, consumer discretionary led gains, buoyed by Tesla's 8% gain, while materials underperformed.
In fixed income, Treasury yields declined for a fourth straight session, underscoring how critical Trump's early-week reassurance — that he would not dismiss Fed Chair Jerome Powell — was for bond market sentiment.
The yield on the 10-year Treasury note dropped 4 basis points to 4.27%, on course for its lowest close since April 8.
In commodities, gold slid 2%, oil held steady at $62 per barrel, and natural gas rose 1% to $3 per million British thermal units, snapping a 10-session losing streak.
In crypto markets, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 1.2% to $95,000.
<h2 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,250.90</td>
<td>+0.2%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,488.71</td>
<td>+0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,908.60</td>
<td>-0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,942.82</td>
<td colspan="2">-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) flattened at $546.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.5% to $399.23.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;fell 0.2% to $468.61.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.7% to $192.79.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 1.1%; the&nbsp;Materials Care&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
Stocks reacting to earnings report included:
<ul>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): up 1.7%</li>
<li>T-Mobile US Inc.: down 10.9%</li>
<li>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>): up 2.4%</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>): down 7.2%</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): down 3.2%</li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>): down 11.0%</li>
<li>Republic Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>): down 0.2%</li>
<li>Digital Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>): up 3.0%</li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>): down 5.2%</li>
<li>Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>): up 10.3%</li>
<li>The Hartford Financial Services Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>): down 1.1%</li>
<li>Weyerhaeuser Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>): down 2.1%</li>
<li>Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>): up 1.1%</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>): down 7.7%</li>
<li>LyondellBasell Industries N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>): up 0.0%</li>
<li>VeriSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>): up 9.1%</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>): down 2.0%</li>
<li>Carrier Global Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>): down 0.5%</li>
<li>Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>): down 0.7%</li>
<li>Erie Indemnity Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>): down 11.8%</li>
<li>Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>): down 1.4%</li>
<li>Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>): down 6.0%</li>
<li>Healthpeak Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>): down 4.7%</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45009066/goldman-sachs-upgrades-charles-schwab-to-buy-one-of-the-best-earnings-growth-outlooks-analyst-says">Goldman Sachs Upgrades Charles Schwab To Buy: &#8216;One Of The Best Earnings Growth Outlooks,&#8217; Analyst Says</a></li>
</ul>
Photo: Shutterstock

Comments

Colgate-Palmolive

뉴스

에 대한 최신 뉴스 Colgate-Palmolive (NYSE:CL) 주식

목요일, 6월 05, 2025

토요일, 5월 17, 2025

금요일, 4월 25, 2025

화요일, 4월 08, 2025

금요일, 1월 31, 2025

금요일, 10월 25, 2024

일요일, 7월 21, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌